Gataparsen (sodium)
Gataparsen sodium is an antisense oligonucleotide directed against survivin mRNA with potential antitumor activity.
Product Specifications
Product Name Alternative
LY 2181308 (sodium)
UNSPSC
12352208
Target
Survivin
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
[Gataparsen(sodium)]
References & Citations
[1]Wiechno P, Somer BG, Mellado B, et al. A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer. Eur Urol. 2014;65 (3) :516-520.|[2]Tanioka M, Nokihara H, Yamamoto N, et al. Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011;68 (2) :505-511.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC743168-500 1x 500 µL
GRP94 / HSP90B1 (Glucose-Regulated Protein 94) (Endoplasmic Reticulum Marker) (HSP90B1/3168R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
